docetaxel anhydrous has been researched along with Coronary Restenosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angsantikul, P; Carpenter, C; Chen, TC; Chien, S; Dehaini, D; Fang, RH; Gao, W; Hofman, FM; Hu, CM; Kroll, AV; Luk, BT; Nguyen, P; Patel, SH; Qu, V; Ramesh, M; Shi, W; Thamphiwatana, S; Wang, KC; Wen, CH; Zhang, K; Zhang, L; Zhu, J | 1 |
| Reddy, HK; Sturek, M | 1 |
2 other study(ies) available for docetaxel anhydrous and Coronary Restenosis
| Article | Year |
|---|---|
Nanoparticle biointerfacing by platelet membrane cloaking.
Topics: Animals; Anti-Bacterial Agents; Blood Platelets; Blood Vessels; Cell Membrane; Collagen; Complement Activation; Coronary Restenosis; Disease Models, Animal; Docetaxel; Drug Delivery Systems; Humans; Macrophages; Male; Mice; Nanoparticles; Platelet Adhesiveness; Polymers; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Taxoids; Unilamellar Liposomes; Vancomycin | 2015 |
New tools for prevention of restenosis could decrease the "oculo-stento" reflex.
Topics: Angioplasty, Balloon, Coronary; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Coronary Restenosis; Coronary Stenosis; Docetaxel; Drug Implants; Humans; Injections, Intra-Arterial; Models, Animal; Paclitaxel; Rabbits; Rats; Sirolimus; Stents; Taxoids | 2002 |